openPR Logo
Press release

Protein Therapeutics Market: Advancements in Biotechnology Driving Growth in Targeted Disease Treatment

09-15-2023 04:15 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Protein Therapeutics Market: Advancements in Biotechnology

The global protein therapeutics market size was valued at $283.64 Billion in 2020, and is estimated to reach $566.66 Billion by 2030, growing at a CAGR of 7.1% from 2021 to 2030.

Growing Market: The protein therapeutics market has experienced significant growth over the years and continues to expand. This growth can be attributed to factors such as increasing prevalence of chronic diseases, advancements in biotechnology and genetic engineering, and a rising demand for personalized medicine.

Request Sample Copy of Report:

https://www.alliedmarketresearch.com/request-sample/60

Wide Range of Applications: Protein therapeutics are used to treat a diverse range of diseases and conditions. They have been successfully employed in the treatment of cancer, autoimmune disorders, infectious diseases, metabolic disorders, and many other therapeutic areas.

Monoclonal Antibodies Dominate: Monoclonal antibodies (mAbs) are the most commonly used protein therapeutics. They account for a significant share of the market and have been highly successful in treating various diseases, including cancer and autoimmune disorders.

Market Drivers:

Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders, is a significant driver for the protein therapeutics market. Protein-based drugs offer targeted treatment options for these diseases, improving patient outcomes and quality of life.

Advancements in Biotechnology and Genetic Engineering: Technological advancements in biotechnology and genetic engineering have greatly facilitated the development of protein therapeutics. Techniques such as recombinant DNA technology, protein engineering, and high-throughput screening have accelerated the discovery, production, and optimization of protein-based drugs.

Market Segmentation:

Product Type: Protein therapeutics can be classified into different types based on their mode of action and composition. Some common product types include:

a. Monoclonal Antibodies (mAbs): These are antibodies produced from a single clone of cells and are widely used in the treatment of various diseases.

b. Insulin: Insulin is a protein therapeutic used in the management of diabetes.

c. Interferons: Interferons are proteins that play a crucial role in the immune response and are used to treat conditions such as hepatitis and multiple sclerosis.

d. Growth Factors: Growth factors are proteins that regulate cell growth and division and are used in therapies for conditions such as cancer and blood disorders.

e. Enzymes: Enzymes are proteins that catalyze biochemical reactions and can be used therapeutically for enzyme replacement therapies.

f. Fusion Proteins: Fusion proteins are created by combining parts of different proteins and can have multiple therapeutic actions.

g. Peptide Hormones: Peptide hormones, such as erythropoietin and growth hormone, are used to regulate various physiological processes.

Therapeutic Area: Protein therapeutics are used in the treatment of a wide range of diseases and conditions. Segmentation by therapeutic area includes:

a. Oncology: Protein therapeutics play a significant role in cancer treatment, with mAbs being widely used in targeted therapies.

b. Autoimmune Disorders: Protein therapeutics are used to modulate the immune response in conditions like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.

c. Metabolic Disorders: Protein therapeutics are employed in the management of metabolic disorders such as diabetes, hypercholesterolemia, and lysosomal storage diseases.

d. Infectious Diseases: Protein-based drugs can be used to target infectious agents, such as viruses and bacteria, and boost the immune response against them.

e. Cardiovascular Disorders: Protein therapeutics are explored for their potential in treating cardiovascular conditions like heart failure and thrombosis.

f. Hematological Disorders: Protein therapeutics, including clotting factors and growth factors, are used in the management of blood disorders.

g. Neurological Disorders: Protein therapeutics may be used in the treatment of neurological conditions like Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

Technology: Segmentation based on technology focuses on the different approaches used in protein therapeutic development and production. This can include:

a. Recombinant DNA Technology: This involves the use of genetic engineering to produce proteins in host expression systems.

b. Hybridoma Technology: Hybridoma technology is used for the production of monoclonal antibodies.

c. Protein Engineering: Protein engineering techniques are employed to modify or optimize the properties of therapeutic proteins.

d. Cell and Gene Therapies: This segment includes protein therapeutics produced using cell-based and gene-based therapies, such as CAR-T cell therapies.

e. Biosimilars: Biosimilars are protein therapeutics that are highly similar to approved reference biologic drugs and offer cost-effective alternatives.

Geography: The protein therapeutics market can also be segmented by geography, including regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Different regions may have varying market dynamics, regulatory landscapes, and healthcare infrastructure.

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/60

Competitive Landscape

Roche Holding AG
Amgen Inc.
Novo Nordisk A/S
Johnson & Johnson
Pfizer Inc.
AbbVie Inc.
Sanofi SA
Merck & Co., Inc.
Eli Lilly and Company
Bristol Myers Squibb Company

Buy this Premium Research Report: https://www.alliedmarketresearch.com/purchase-enquiry/60

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

More Reports:

Defibrillators Market https://www.alliedmarketresearch.com/defibrillator-market

Cancer Biomarkers Market https://www.alliedmarketresearch.com/cancer-biomarkers-market

Bone Grafts and Substitutes Market https://www.alliedmarketresearch.com/bone-graft-substitutes-market

Dialysis Market https://www.alliedmarketresearch.com/dialysis-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Protein Therapeutics Market: Advancements in Biotechnology Driving Growth in Targeted Disease Treatment here

News-ID: 3210400 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Protein

Cell-Free Protein Synthesis Market Forecast: Opportunities in High-Throughput Pr …
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth USD 299.9 million in 2024 and is poised to reach USD 585.3 Million by the year 2034, growing at a CAGR of 7.0% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1445 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global cell-free
Plant Protein Market : Latest Market Research Report for Strategic Advantage | S …
Global Plant Protein Market Market Overview: Global Plant Protein Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Plant Protein involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters
Pea Protein Ingredients Market Prospects, Consumption, Cost Structure, Competiti …
The food industry is continuously searching for healthier and cheaper protein ingredients that can be replaced by animal-based and gluten-based proteins. Pea protein is beneficial due to its low allergenicity, availability, and high nutritional value. The Global Pea Protein Ingredients Market is witnessing a major rise in its revenue from US$ 2.35 Bn in 2021 to US$ 6.78 Bn by 2030. The market is recording a CAGR of 12.5% during
Astonishing growth in Dairy Protein Market Growth? Milk Protein Isolates (MPIs), …
Dairy Protein Market Business Insights and Updates: The latest Market report by a Data Bridge Market Research with the title [Global Dairy Protein Market - Industry Trends and Forecast to 2026] . Dairy Protein Market research analysis and data lend a hand to businesses for the planning of strategies related to COVID-19 impact on industry, investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. Dairy Protein market insights with
Global Plant Protein Market 2019 – Soy Protein, Wheat Protein, Pea Protein | K …
The Global Pea Protein Market Research Report conducts a deep estimation on the present state of Pea Protein Industry with the definition, classification and market scope. The fundamental Pea Protein Industry aspects like competitive landscape structure, eminent industry players, Pea Protein Market size and value is studied. The Pea Protein Market growth trends, development plans, dynamic market driving factors and risk assessment is conducted. All the traders, dealers, distributors of
Protein Packaging Market Report 2018: Segmentation by Product (Rigid packaging, …
Global Protein Packaging market research report provides company profile for Amcor Limited, DuPont, Flexifoil Packaging Pvt., Swiss Pac Private Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed